Literature DB >> 34231480

Patients with Specific Gastrointestinal Motility Disorders are Commonly Diagnosed as Functional GI Disorders in the Early Stage by Community Physicians due to Lack of Awareness.

Uday C Ghoshal1, Bhavesh Bhut1, Asha Misra1.   

Abstract

BACKGROUND: Data on specific gastrointestinal (GI) motility disorders, such as gastroparesis (GP), chronic intestinal pseudo-obstruction (CIPO), and colonic inertia (CI), as well as awareness among doctors about these disorders are scanty in Asia.
METHOD: Prospectively maintained records of 60 patients were retrospectively analyzed, and knowledge, attitude, and practice (KAP) of 66 Indian physicians were surveyed electronically.
RESULTS: A total of 60 (age 37.7 ± 18.4 years, 25 female) patients were included in the study (13 [21.7%] GP, 25 [41.7%] CIPO, 14 [23.3%] CI, and 8 [13.3%] overlap of GP and either CIPO [5] or CI [3]), of whom 40 had primary disorders and 20 had secondary disorders due to diabetes mellitus (n = 6), systemic sclerosis (n = 4), paraneoplastic (n = 2), infection (n = 3), Parkinson's disease (n = 1), hypothyroidism (n = 1), hyperparathyroidism (n = 1), celiac disease (n = 1), and amyloidosis (n = 1). Primary disorders were more often misdiagnosed as functional GI disorders, causing diagnostic delays and complications, than secondary disorders. More patients in the primary disorder group underwent surgery compared with those in the secondary group (25/40, 62.5% vs 1/20, 5%). A few rare infectious causes of GI motility disorders due to Strongyloides stercoralis, herpesvirus, and unidentified viruses were found. Of four patients treated with pyridostigmine with (n = 3) or without prucalopride (n = 1), three responded. Awareness about GI motility disorders, particularly the primary disorders, among 66 doctors participating in the KAP survey was inadequate.
CONCLUSION: Awareness regarding specific GI motility disorders among physicians is lacking, which leads to delay in diagnosis and results in more complications in patients, such as surgery, particularly in those with primary disorders.

Entities:  

Mesh:

Year:  2021        PMID: 34231480      PMCID: PMC8975340          DOI: 10.5152/tjg.2021.20514

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  39 in total

Review 1.  Treatment of gastroparesis: a multidisciplinary clinical review.

Authors:  T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik
Journal:  Neurogastroenterol Motil       Date:  2006-04       Impact factor: 3.598

2.  Transient gastroparesis associated with cutaneous herpes zoster.

Authors:  D Kebede; J S Barthel; A Singh
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

3.  Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study.

Authors:  Rajiv Mehta; Anil John; Prem Nair; V V Raj; C P Mustafa; Deepak Suvarna; V Balakrishnan
Journal:  J Gastroenterol Hepatol       Date:  2006-02       Impact factor: 4.029

4.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

5.  The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.

Authors:  Jessica Robinson-Papp; Alexandra Nmashie; Elizabeth Pedowitz; Mary Catherine George; Sandeep Sharma; Jacinta Murray; Emma K T Benn; Steven A Lawrence; Josef Machac; Sherif Heiba; Seunghee Kim-Schulze; Allison Navis; Bani Chander Roland; Susan Morgello
Journal:  J Neurovirol       Date:  2019-05-16       Impact factor: 2.643

6.  Evaluation of interstitial cells of Cajal in patients with severe colonic inertia requiring surgery: a clinical-pathological study.

Authors:  M Cohen; D Cazals-Hatem; H Duboc; J-M Sabate; S Msika; A L Slove; Y Panis; B Coffin
Journal:  Colorectal Dis       Date:  2017-05       Impact factor: 3.788

7.  Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Dragos Creţoiu; Sanda Maria Creţoiu; Gabriel Becheanu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

8.  The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine.

Authors:  C J O'Dea; J H Brookes; D A Wattchow
Journal:  Colorectal Dis       Date:  2010-06       Impact factor: 3.788

Review 9.  Toward a definition of colonic inertia.

Authors:  Gabrio Bassotti; Giuseppe-De Roberto; Luca Sediari; Antonio Morelli
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

10.  Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility.

Authors:  J Broad; V W S Kung; G Boundouki; Q Aziz; J H De Maeyer; C H Knowles; G J Sanger
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

View more
  2 in total

Review 1.  Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.

Authors:  Rajan Singh; Hannah Zogg; Uday C Ghoshal; Seungil Ro
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

2.  Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.

Authors:  Uday C Ghoshal; Sanjeev Sachdeva; Ujjala Ghoshal; Asha Misra; Amarender Singh Puri; Nitesh Pratap; Ayesha Shah; M Masudur Rahman; Kok Ann Gwee; Victoria P Y Tan; Tahmeed Ahmed; Yeong Yeh Lee; B S Ramakrishna; Rupjyoti Talukdar; S V Rana; Saroj K Sinha; Minhu Chen; Nayoung Kim; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.